Skip to content

EMERGEX VACCINES LTD vs Emmes

EMERGEX VACCINES LTD logo

EMERGEX VACCINES LTD

A UK biotechnology company developing T cell-priming immune set-point candidates against infectious diseases

1 employees · est. 2016 · United Kingdom

VS
Emmes logo

Emmes

The Industry’s First Native Digital and AI Specialty CRO

1294 employees · est. 1977 · Rockville, United States

Emmes is the older company (2016 vs 1977); Emmes is the larger of the two.

Side-by-Side Comparison

EMERGEX VACCINES LTD Emmes
Founded
2016 1977 older
Headquarters
United Kingdom Rockville, United States
Employees
1 1294 larger
Industry
Biopharma, Biotechnology, Health Care Biopharma, Biotechnology, Health Care
Funding Stage
Grant Private Equity
Total Funding
$12.47M Not tracked yet
Funding Rounds
4 1
Taxonomy
T Cell-Priming VaccinesInfectious DiseasesClinical-Stage BiotechnologyImmunotherapyVaccine DevelopmentPandemic Prevention +8 Contract Research OrganizationClinical ResearchPublic HealthBiopharmaceutical InnovationVaccinesInfectious Diseases +8
Website
emergexvaccines.com emmes.com
EMERGEX VACCINES LTD logo

About EMERGEX VACCINES LTD

Emergex Vaccines is a pioneering UK biotechnology company that focuses on developing T cell-priming immune set-point candidates to combat infectious diseases. Founded in 2016, the company has its headquarters in the United Kingdom and an operating subsidiary in Pennsylvania, USA. Emergex's innovativ...

Emmes logo

About Emmes

Emmes is a leading Contract Research Organization that has been at the forefront of clinical research for over 40 years. Headquartered in the United States and with offices in Europe, Canada, and India, Emmes is dedicated to conducting clinical research with scientific rigor and compliance with glob...

Also comparing in this category

Comparing more than these two?

Get EMERGEX VACCINES LTD, Emmes and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does EMERGEX VACCINES LTD compare?

A PDF of EMERGEX VACCINES LTD and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

EMERGEX VACCINES LTD was founded in 2016, based in United Kingdom, with 1 employees. Emergex Vaccines is a pioneering UK biotechnology company that focuses on developing T cell-priming immune set-point candidates to combat infectious diseases. Founded in 2016, the company has its head. Emmes was founded in 1977, based in Rockville, United States, with 1,294 employees. Emmes is a leading Contract Research Organization that has been at the forefront of clinical research for over 40 years. Headquartered in the United States and with offices in Europe, Canada, and Indi.
EMERGEX VACCINES LTD has raised $12.47M and Emmes no disclosed funding. Latest stage: EMERGEX VACCINES LTD Grant, Emmes Private Equity.
Both work in Biopharma, Biotechnology and Health Care and list infectious diseases and public health among their focus areas.

Compare EMERGEX VACCINES LTD with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at EMERGEX VACCINES LTD on 11 Sep 2024, and Emmes on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout